drugset / Trial / NCT00219570
Dalacin-T Gel Post Approval Study
Phase 4
Completed
134 enrolled
Pfizer
Acronet · collabBellsystem24 , Inc. · collabMitsubishi Kagaku Bio-Clinical Laboratories, inc · collabParexel · collabSACT INTERNATIONAL Co., LTD. · collabSATO Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.
Timeline
- Start
- 2005-01
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clindamycin | Unknown | — | Topical |
| Subject | nadifloxacin | Unknown | — | Topical |